GLP-1 Microdose Starter (Semaglutide)
A physician-evaluated set of options commonly discussed together. Each item is reviewed individually; inclusion here is not a recommendation or a promise of results.
Your step-by-step path
-
Step 1: Required: GLP-1 Panel (start here) ($50.00)
Baseline labs your physician reviews to assess eligibility and safety before GLP-1 therapy.
GET STARTED -
Step 2: Metabolic Health Panel ($111.25)
Core metabolic, kidney and liver markers your physician may use for safety monitoring.
GET STARTED -
Step 3: Semaglutide Microdose Injection with B12 ($125.00)
A lower-dose semaglutide option. Microdosing is not an established regimen; any dosing is set by your physician.
GET STARTED
Why this order: Baseline labs come first so your partner physician can confirm eligibility and safety before any prescription; GLP-1 treatment, when prescribed, starts at the lowest dose with physician-guided titration per the medication label.
This sequence is educational. Your partner physician will determine whether this is appropriate for you. Your partner physician confirms the final plan, order and timing.
Important: Microdosing is not an established regimen. Standard, approved dose titration is the validated approach. Your partner physician will determine whether this is appropriate for you.
WITH CEVII, YOU'RE NOT JUST GETTING A PRODUCT OR A SUBSCRIPTION. YOU'RE GETTING A GUIDED JOURNEY AND A STRATEGIC PLAN, BUILT WITH YOUR PARTNER PHYSICIAN, TO SUPPORT YOUR HEALTH AND HELP YOU REACH YOUR FULL POTENTIAL.
Combined price: $286.25 (each item billed at its individual price)
That's about $9.54/day over a 30-day month
Prescription items require partner physician approval at intake; cosmetic add-ons do not. Your partner physician reviews your health history and labs, determines whether each item is appropriate, and may adjust or remove any item. No specific result is promised.
Prescription only. Every treatment is prescribed by a licensed partner physician and prepared by licensed U.S. pharmacies. No research chemicals. No gray-market compounds.
Educational information only. Not medical advice. Individual results vary.